In developed nations, prostate cancer is the most commonly diagnosed non-cutaneous malignancy among males. Standard forms of treatment for prostate cancer detected at a localized stage include radical ...

A new editorial paper was published in Oncotarget titled "Unveiling the non-canonical functions of EZH2 in prostate cancer." Prostate cancer (PCa) is ranked as the second leading cause of ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

Please provide your email address to receive an email when new articles are posted on . Exercise 3 days a week conferred more benefit than usual care for men with prostate cancer and erectile ...

The proapoptotic protein, prostate apoptosis response-4 (Par-4), acts as a tumor suppressor in prostate cancer cells. The serine/threonine kinase casein kinase 2 (CK2) has a well-reported role in ...

Tallmadge, OH, April 03, 2026 (GLOBE NEWSWIRE)-- This report presents publicly available information about ProstaCleanse, including ingredient-level research context, company-provided product details, ...